AzTrials
AzTrials

ObesityNCT01664026

Efficacy of a Web-based Lifestyle Modification Program in Obese Patients With Cardiovascular Risk Factors

A study testing Web-based lifestyle modification and Web-based lifestyle modification + in people with Obesity, run by Clínica Bazterrica at 1 site in Argentina.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

To evaluate the effect of a 6-month web-based lifestyle modification program with and without telephone counseling versus usual care in obese patients with cardiovascular risk factors on: Weight Loss Waist circumference; blood pressure; total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol; glucose and… Read more about this study

Who is it for?
Ages 25 to 70 years
Conditions the study is for
Obesity
What is being tested?
Web-based lifestyle modification and Web-based lifestyle modification +
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteArgentina
Study dates
Aug 2012to Dec 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male or female 25-70 years of age
  • Obese (BMI ≥ 30 kg/m2 and <40 kg/m2)
  • At least 2 cardiovascular risk factors (diabetes, hypertension or dyslipidemia) i) Hypertension defined by a history of hypertension, treatment of hypertension or BP values >140/90 mmHg in two consecutive office visits ii) High cholesterol defined by an LDL-C ≥130 mg/dL and/or HDL-C <40 mg/dL and triglycerides ≥150 mg/dL iii) Type 2 Diabetes Mellitus defined by a history of diabetes, treatment of diabetes or fasting glucose ≥126 mg/dL in two consecutive office visits
  • Participant must be willing and able to provide written informed consent
  • Participant must be willing and able to comply with study related procedures
  • Participant must have access to Internet and e-mail

Who cannot join

  • Stage 1 or 2 on Patient Activation Measures tool
  • Weight change of more than 5 kg during the 3 months preceding the screening visit
  • History of bariatric surgery
  • Fasting Plasma Glucose at screening > 250 mg/dL (> 13.9 mmol/L)
  • Hemoglobin A1c at screening >8.5%
  • Treatment of type 2 diabetes with insulin (except for history of intermittent acute use, no more than 2 weeks usage in previous 6 months)
Show all 15Show fewer
  • Uncontrolled or inadequately controlled hypertension at the time of screening with blood pressure >160/100 mmHg
  • Secondary hypertension
  • Changes in lipid, blood pressure or diabetes modifying agents including introduction, change in dose or cessation in the 3 months prior to Screening Visit
  • Personal history of coronary heart disease, congestive heart failure, serious arrhythmias and stroke
  • Cardiovascular, hepatic, neurological, endocrine disease, active malignant tumor or other major systemic disease making implementation of the protocol or interpretation of the study results difficult.
  • Presence of any condition (medical, psychological, social, or geographical), actual or anticipated, that in the opinion of the Investigator would restrict or limit the patient's successful participation for the duration of the study
  • Presence of history of cancer within the past five years with the exception of adequately treated localized basal cell skin cancer or in situ uterine cervical cancer
  • Use of systemic glucocorticoids (excluding topical application or inhaled forms) for one week or more within 3 months prior to the time of screening
  • Use of any investigational agent (drug, biologic, device) within 3 months prior to screening

Trial locations and contacts

1 site in 1 country.

Argentina1 site
  • Clinica Bazterrica

    Buenos Aires

Other trials in Argentina

About this study

Official title: A 6-Month, Randomized Study to Evaluate the Efficacy of a Web-based Lifestyle Modification Program With and Without Telephone Counseling Support

To evaluate the effect of a 6-month web-based lifestyle modification program with and without telephone counseling versus usual care in obese patients with cardiovascular risk factors on:

  • Weight Loss
  • Waist circumference; blood pressure; total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol; glucose and hemoglobin A1c; C-reactive protein.
  • Physical activity and eating habits
  • Quality of life
Conditions
Obesity
Being tested
Web-based lifestyle modification, Web-based lifestyle modification +
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Web-based lifestyle modificationBehavioural

    Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance.

  • Web-based lifestyle modification +Behavioural

    Access to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance plus telephone counseling support by health coaches on a weekly or bi-weekly basis.

Study groups in NCT01664026
Study groupRoleWhat they receive
ControlNo interventionSubjects assigned to the usual care group will receive general lifestyle recommendations as per their country standards of care.
WebExperimentalAccess to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance.
Receives: Behavioral: Web-based lifestyle modification
Web+ExperimentalAccess to a web-based lifestyle modification program of 6-month duration that covers all aspects of a healthy lifestyle including physical activity, nutrition and weight maintenance plus telephone counseling support by health coaches on a weekly or bi-weekly basis.
Receives: Behavioral: Web-based lifestyle modification +

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in body weight from randomization to 6 months

    Measured: 6 months

Secondary outcomes (5)
  1. Changes in waist circumference

    Measured: 6 months

  2. Changes in blood pressure

    Measured: 6 months

  3. Changes in lipid parameters (total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol)

    Measured: 6 months

  4. Changes in glycemic parameters (glucose and hemoglobin A1c)

    Measured: 6 months

  5. Changes in C-reactive protein

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2012 (estimated)
  2. Study startAug 2012
  3. Primary completionAug 2013 (estimated)
  4. Study completionDec 2013 (estimated)

Why it stopped: Lack of funds

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01664026
Sponsor's protocol ID
PWeb123
Status last verified
Jan 2019
First submitted
9 Aug 2012
Last updated
1 Feb 2019
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Web-based lifestyle modification and Web-based lifestyle modification + in people with Obesity, run by Clínica Bazterrica at 1 site in Argentina.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 1 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Argentina. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in body weight from randomization to 6 months (time frame: 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Feb 2019; AzTrials last refreshed its copy on 30 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in